Literature DB >> 24944004

Biomechanical analysis of the splenic avulsion mechanism.

Omar Chebil1, Michel Behr, Florent Auriault, Pierre-Jean Arnoux.   

Abstract

The spleen is a frequently injured abdominal organ in road accidents, with an injury frequency close to 30%. The splenic avulsion exhibit a significant ratio of morbidity. It is clinically described as the complete failure of the pancreatico-splenic ligament (PSL) which is composed of splenic vessels and connective tissues. What are the biomechanical mechanisms involved with spleen avulsion? Is it possible to quantify tolerance levels of PSL structure? The current work combines both experimental and finite element (FE) investigations to determine the splenic avulsion process. Tensile tests on 13 PSL samples were performed up to failure. The experimental results provide reference data for model validation and showed a failure process starting at a peak force of 70±34 N combined with a peak strain of 105±26%. In an attempt to identify possible vessel ruptures within the PSL, a FE model of the PSL was developed including both vessels and connective tissues. The vessel wall behaviour up to failure was reproduced using an Ogden law and calibrated by inverse analysis according to literature data. The connective tissues function was modelled by a cohesion-loss interface. Once model correlation to experimental results was achieved, numerical simulation revealed that haemorrhage could occur even before the maximum peak is reached. Indeed, the first vessel ruptures were recorded at a strain of 92% at the upper lobe vein.

Entities:  

Mesh:

Year:  2014        PMID: 24944004     DOI: 10.1007/s11517-014-1166-6

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  17 in total

1.  Viscoelastic properties of human skin and processed dermis.

Authors:  F H Silver; J W Freeman; D DeVore
Journal:  Skin Res Technol       Date:  2001-02       Impact factor: 2.365

2.  Elastic behavior of porcine coronary artery tissue under uniaxial and equibiaxial tension.

Authors:  C Lally; A J Reid; P J Prendergast
Journal:  Ann Biomed Eng       Date:  2004-10       Impact factor: 3.934

3.  Reducing the number of vocal fold mechanical tissue properties: evaluation of the incompressibility and planar displacement assumptions.

Authors:  Douglas D Cook; Eric Nauman; Luc Mongeau
Journal:  J Acoust Soc Am       Date:  2008-12       Impact factor: 1.840

4.  Strain energy density as a rupture criterion for the kidney: impact tests on porcine organs, finite element simulation, and a baseline comparison between human and porcine tissues.

Authors:  J G Snedeker; M Barbezat; P Niederer; F R Schmidlin; M Farshad
Journal:  J Biomech       Date:  2005-05       Impact factor: 2.712

5.  Changes in radiation dose with variations in human anatomy: larger and smaller normal-stature adults.

Authors:  Patrick M Marine; Michael G Stabin; Michael J Fernald; Aaron B Brill
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

6.  Organ injury scaling: spleen and liver (1994 revision).

Authors:  E E Moore; T H Cogbill; G J Jurkovich; S R Shackford; M A Malangoni; H R Champion
Journal:  J Trauma       Date:  1995-03

7.  Failure properties of passive human aortic tissue. I--uniaxial tension tests.

Authors:  D Mohan; J W Melvin
Journal:  J Biomech       Date:  1982       Impact factor: 2.712

8.  Biomechanical characterization of internal layer subfailure in blunt arterial injury.

Authors:  Brian D Stemper; Narayan Yoganandan; Grant P Sinson; Thomas A Gennarelli; Michael R Stineman; Frank A Pintar
Journal:  Ann Biomed Eng       Date:  2006-12-07       Impact factor: 3.934

9.  Anatomy of vasculature of 850 spleen specimens and its application in partial splenectomy.

Authors:  D L Liu; S Xia; W Xu; Q Ye; Y Gao; J Qian
Journal:  Surgery       Date:  1996-01       Impact factor: 3.982

10.  The fatal injuries of car drivers.

Authors:  A Ndiaye; M Chambost; M Chiron
Journal:  Forensic Sci Int       Date:  2008-12-25       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.